TIP-B1 could be used as an independent prognostic marker for KIRC patients who have undergone surgery, which not only provide a novel therapeutic strategy for future KIRC management, but also provide a potential target for cancer prevention and treatment. This evidence concerns the gene SH3BGRL3 and cancer.